Lipocine Inc
LPCN
$2.66+26.43%
Delayed · as of Oct 7, 2026, 10:15 AM ET
Mkt cap
$19.29M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$1.98M
EPS (TTM)
$-1.77
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-487.06%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported LPCN revenue for 2025-12-31 was $2.0M. Net income was -$9.6M. Revenue was up 169.3% from 2023-12-31 to 2025-12-31. LPCN currently screens at market cap $19.3M.
Use this LPCN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LPCN income, balance, and cash tables.
Lipocine Inc (LPCN) is a biotechnology company in the Healthcare sector.
Latest cached Lipocine Inc (LPCN) revenue for Dec 31, 2025 was $2.0M. Net income was -$9.6M. Statements: https://lician.com/financials/lpcn
Lipocine Inc (LPCN) market capitalization is $19.3M on the latest cached snapshot.
Lipocine Inc (LPCN) cached previous close $2.10; day range $2.50 – $3.14; volume 88,194,115. Session quote: https://lician.com/quote/lpcn